August 11, 2023 07:02 AM EDT
R&D
Law

Hen­ri­et­ta Lack­s' fam­i­ly sues Ul­tragenyx over use of im­mor­tal HeLa cell line, claim­ing un­just en­rich­ment

Katherine Lewin

News Reporter

The fam­i­ly of Hen­ri­et­ta Lacks has sued again over the use of her im­mor­tal cell line, this time go­ing af­ter Ul­tragenyx in Mary­land Dis­trict Court …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The elec­tion is Tues­day. What’s at stake for the phar­ma in­dus­try?

'We play to win': As­traZeneca de­tails first re­sults for oral GLP-1 and broad­er obe­si­ty am­bi­tions

Is there room for MASH drugs in a GLP-1 world?

Viking's oral weight loss drug ap­pears to have strong ef­fect in Phase 1 tri­al

BioN­Tech says VEGF bis­pe­cif­ic’s PD-L1 tar­get, com­bo plans will be its edge

sponsored

Gene ther­a­pies don’t have to cost $4 mil­lion: New pro­duc­tion plat­forms re­duce de­vel­op­ment costs and risks

A service from the Financial Times